Article
The importance of real-world data in evaluating the safety of biosimilars: a descriptive study of clinical practice in an oncohematological population.
2024-03-15
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold> Safety concerns are often raised when switching from reference to biosimilar products and between different biosimilars. <bold>Objective</bold> The objective of this multicenter observational study is to provide an objective and representative Italian-level picture of RTX use in individuals with oncohematologic diseases during the period 2018-2022. <bold>Results<...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- dfa22d49-cf71-5b07-95a5-561e0f965110
- DOI
- 10.21203/rs.3.rs-3994336/v1